停吃面包和烘焙食品五天，最多十天内就能改善 85% 的反流和肠易激综合征症状；这两种疾病都可以被彻底消除。
原始表述
لو بطلوا انهارددة العيش البلدي والمخبوزات بتضيق الصافي لمدة خمسة ايام خمسة وثمانون في المائة من اعراض الارتجاع وأراض القانون العصبي هتحسن [01:27] عصبي هتتحسن انمكنش هتروح كلها لحد اقصي. عشرة ايام
按来源为原话. 译文由本项目提供；以阿拉伯语原文为准。
译文
停吃面包和烘焙食品五天，最多十天内就能改善 85% 的反流和肠易激综合征症状；这两种疾病都可以被彻底消除。
出处
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- علاج الحموضة فى خطوة واحدة بس .. ماحدش فكر فيها قبل كده (打开来源)
- 发布日期
- 2021年3月12日
- 时间戳
- 无（转录文本不含时间信息）
- 归属的不确定性
- Archive transcript with time markers; wording partly garbled.
- 所声称的机制
Removal of bread removes the cause.
- 所声称的健康影响
85% symptom improvement; complete cure.
- 涉及人群
People with reflux and IBS.
- Elawady 设定的地域限制
none found
来源版本存在差异
الحموضة أو ارتجاع المرئ والقولون العصبي مرضين في الجهاز الهضمي ممكن نتخلص منهم تماما لو بطلنا عادات سيئة كتير بنعملها في أكلنا لو شوية تحسين في التغذية بتاعتنا هتختفي كل الاعراض دي الحموضة العيانين بيشتكوا منها ويروحوا يتعلقوا منها بأدوية بتقلل الحموضة زي الرنتي دي [00:29] زي الرانيتيدين والكنترولات وبعد شوية يكتشفوا ان عندهم جرثوم حلزونية يااخدوا لي لها علاج لا الجرثومة بتخف ولا الارتجاع بيقل مجر ما يوقف الدوااء النهارده الارتجاع بيزيد
- 来源状态
- 视频转录文本（本人原话）
- 归属
- Elawady (machine transcript)
- 视频
- علاج الحموضة فى خطوة واحدة بس .. ماحدش فكر فيها قبل كده (打开来源)
- 发布日期
- 2021年3月12日
- 时间戳
- 无（转录文本不含时间信息）
科学评估
基本错误 – 该说法的主要部分没有证据支持，或被严重夸大。
证据确定性: 中 – 进一步研究仍可能影响该评估。
1. 说法是什么？
85% improvement in 5–10 days after stopping bread; complete elimination of reflux and IBS.
2. 哪些内容可证实是正确的？
Some patients improve with dietary change (see C-GUT-01).
3. 哪些内容是错误或夸大的？
The 85% figure has no identified source. The statement that both diseases can be 'eliminated completely' through habits contradicts guidelines that recommend drugs, psychotherapy and other measures because diet alone often does not suffice.
4. 哪些内容仍不明确？
Elawady's clinical experience is not documented in a published, controlled form.
5. 哪些研究支持该说法？
None.
6. 哪些研究与该说法相矛盾？
ACG IBS 2021 (I-GUT-05) and ACG GERD 2022 (I-PPI-10) recommend multiple treatment options beyond diet. Gluten-free diet RCT: 58% responders at 4 weeks (I-GUT-103); blinded wheat vs sham challenge: no significant difference (39% vs 29% worsening; I-GUT-120); IBS placebo response 27.3% (I-GUT-104); diet NMA (I-GUT-102); lifestyle explains about 37% of GERD symptoms in a large cohort (I-GUT-105). NICE NG12 and CG184 require investigation of alarm symptoms (I-GUT-109, I-GUT-108).
7. 对德国和欧洲而言情况如何？
Not applicable.
8. 关于埃及的已知情况是什么？
Not applicable.
9. 合理的实际结论是什么？
对于快速、几乎人人有效的治愈承诺，应持批判态度；持续存在的症状或警示症状需要就医评估。
评估详情
- 证据确定性的依据
No source for the 85% figure exists. Randomised data now contradict it directly: in the closest trial a gluten-free (wheat-free) diet gave 58% responders after 4 weeks (95% CI 41%-73%; I-GUT-103), a network meta-analysis of 28 RCTs shows diets help a proportion of IBS patients, not nearly all (I-GUT-102), a blinded wheat challenge was not worse than sham in IBS patients who believed wheat harmed them (I-GUT-120), and placebo responses of 27-34% in IBS trials show why uncontrolled success rates are inflated (I-GUT-104). Certainty is moderate because no trial tested the exact regimen.
- 来源质量
Quantitative promise without evidence.
- 地区可推广性
n/a
- 个体例外情况
Some individuals may improve strongly.
- 说法的地域范围
- 未说明
- 最近审核
- 2026年10月26日 初步
科学证据详解
过度解读 – 确有真实的发现，但该说法从中引申出的结论超出了数据所能支持的范围（例如把关联当作因果、把动物数据套用到人身上、把小效应说成大效应）。
研究问题: In people with reflux or IBS, does stopping bread and baked goods for five days improve symptoms in about 85% within 10 days, and can the diseases be eliminated completely?
研究问题详解 (PICO)
- 人群
- Adults with GERD or IBS
- 干预或暴露
- Stopping bread/baked goods
- 对照
- Habitual diet; sham/placebo; other diets
- 地域范围
- universal biology
- 结局指标
- Responder rate
- Time to response
- Remission/cure
- Safety (missed alarm symptoms)
研究结果按作者报告呈现。我们的评估见下文。
哪些证据支持该说法？
Three diets for IBS worked about equally
Rej A et al.. Clin Gastroenterol Hepatol 2022 · PMID 35240330 · DOI 10.1016/j.cgh.2022.02.045 随机对照试验已核查摘要新增The closest trial (gluten-free diet) shows improvement in a majority of IBS patients after 4 weeks, though not 85%.
- 实际结果
- 58% (19/33) responders; Wilson CI 41%-73%
- 方法学质量
- moderate (small RCT)
- 相关性
- direct
- 局限
- No untreated control; 4 weeks, not 10 days
哪些证据不支持该说法？
In a blind test, wheat was not clearly worse than a fake
Seiler CL et al.. Lancet Gastroenterol Hepatol 2025 · PMID 40706614 · DOI 10.1016/S2468-1253(25)00090-1 随机对照试验已核查摘要新增Blinded re-challenge: wheat no worse than sham in IBS patients who believed wheat caused symptoms; expectations played a major role.
- 实际结果
- Worsening 39% wheat vs 29% sham (RD 0.11, -0.16 to 0.35)
- 方法学质量
- high internal validity, imprecise
- 相关性
- direct
- 局限
- n=28
Many IBS patients improve on placebo
Bosman M et al.. Lancet Gastroenterol Hepatol 2021 · PMID 33765447 · DOI 10.1016/S2468-1253(21)00023-6 Meta分析已核查摘要新增About a quarter to a third of IBS patients improve on placebo, so uncontrolled success rates are inflated.
- 实际结果
- Placebo response 27.3% (24.3-30.9) global; 34.4% pain
- 方法学质量
- high (meta-analysis of 73 RCTs)
- 相关性
- indirect (drug trials)
- 局限
- Heterogeneity
Warning signs that need a doctor
National Institute for Health and Care Excellence (NICE). NICE guideline NG12 2015 (last updated 15 April 2026) 指南 / 立场声明已核查全文新增NICE NG12: dysphagia, weight loss with reflux at 55+, haematemesis require referral or endoscopy.
- 实际结果
- Referral criteria
- 方法学质量
- official guideline
- 相关性
- direct for the safety aspect
- 局限
- UK thresholds
总体证据说明了什么？
基于上述研究的编辑评估——其本身并非研究结果。
哪种观点有更好的证据支持？
The 85%-in-10-days figure and the promise of complete elimination are not supported; diet helps a part of patients over weeks, and guidelines require investigation of alarm symptoms.
为什么有些研究权重更大
Randomised and blinded data and placebo-response data outweigh unpublished clinical impressions; no source for the 85% figure was found.
因果关系是否已确立？ 尚未确立 No controlled study tested the specific regimen; the best related RCT shows lower response rates and blinded data attribute much of perceived wheat effects to expectation.
仍存在的不确定性
Response of Egyptian patients to bread removal was never studied.
合理的结论
The quantitative promise is unsupported and the 'complete elimination' statement contradicts guidelines; diet is one part of care.
为什么研究结果看起来互相矛盾？
No real conflict: supportive data show partial response, not cure; the claim's figure appears to derive from uncontrolled observation.
这是否取决于国家？
- 一般生物学效应
- Universal human physiology.
- 饮食习惯
- Not decisive for this claim.
- 食品原产地
- Not relevant.
- 污染物
- Not relevant.
- 本国生产条件
- Not relevant.
- 法律规则
- Not relevant.
- 实际监测数据
- Not applicable.
足以改变结论的地区差异没有可靠数据支持。
统计复核
- Is 85% compatible with trial response rates? – All Wilson 95% CIs (upper limits 59%-73%) exclude 85% 已重新计算
- Placebo response as benchmark – 27.3% (24.3-30.9) placebo response; uncontrolled rates cannot be attributed to diet 无法根据已发表数据重新计算
总体证据的确定性（GRADE，简化版）
- 主要结局
- Proportion of patients with marked improvement or cure after stopping bread
- 起始等级
- 高（随机试验）
- 降级理由
- indirectness (no trial of the exact regimen)
- imprecision (small trials)
- 结果
- 中
由单名审查者参照 GRADE 方法进行的简化评估；并非正式的 GRADE 专家组评估。GRADE 评价的是针对某一结局的整体证据，而非单项研究。
已核查的临床指南和官方声明
- NICE: Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (CG184; I-GUT-108) (2014, updated 2019) · 原始文献
Lifestyle advice (healthy eating, weight reduction, smoking cessation; avoid personal precipitants; main meal well before bed); step down PPIs to lowest effective dose or as-needed unless an underlying condition or comedication needs continuing treatment; same-day referral for dyspepsia with significant acute GI bleeding; long-term full-dose PPI after oesophageal stricture dilatation and as maintenance for severe oesophagitis; H. pylori eradication for H. pylori-positive peptic ulcer; PPI co-prescription with NSAIDs in high-risk people. - NICE: Suspected cancer: recognition and referral (NG12), upper GI section (I-GUT-109) (2015, page updated April 2026) · 原始文献
Suspected cancer pathway referral for dysphagia, or age 55+ with weight loss plus upper abdominal pain, reflux or dyspepsia; consider endoscopy for haematemesis and for age 55+ with treatment-resistant dyspepsia or upper abdominal pain with low haemoglobin. - NICE: Irritable bowel syndrome in adults: diagnosis and management (CG61; I-GUT-110) (2008, updated 2017) · 原始文献
Red-flag assessment and referral; regular meals; at least 8 cups of fluid per day, especially water; reduce alcohol and fizzy drinks; limiting high-fibre foods such as wholemeal/high-fibre flour and breads may help; exclusion diets such as low FODMAP only with a healthcare professional with dietary expertise. - ACG (American College of Gastroenterology): ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease (Katz PO et al. 2022; I-PPI-10) (2022) · 原始文献
Full text read: weight loss recommended for overweight/obese patients (strong, moderate evidence); avoid meals within 2-3 h of bedtime, avoid tobacco, avoid 'trigger foods', elevate head of bed for nocturnal symptoms (conditional, low evidence); Table 3 rates 'avoid carbonated beverages' as moderate evidence and recommendable; PPIs over H2RAs for healing erosive oesophagitis (strong, high evidence); attempt to discontinue PPIs in patients without erosive oesophagitis or Barrett's whose symptoms resolved (conditional, low); maintenance PPI indefinitely or surgery for LA grade C/D oesophagitis (strong, moderate); endoscopy first for dysphagia or alarm symptoms (weight loss, GI bleeding); rebound shown in healthy controls but strong evidence for symptom increase after abrupt withdrawal in patients is lacking.
检索策略
本次审查的文献检索记录（检索式采用原数据库语法）。
| 数据库 | 日期 | 检索式 | 检索目标 | 命中数 | 纳入数 |
|---|---|---|---|---|---|
| PubMed (E-utilities esearch) | 2026年10月26日 | (irritable bowel syndrome[mh]) AND (cure OR remission OR "complete resolution") AND diet[tiab] AND randomized controlled trial[pt] | 支持性证据 | 6 | |
| Europe PMC | 2026年10月26日 | TITLE:"traditional dietary advice" AND TITLE:"gluten-free" | 支持性证据 | 2 | |
| PubMed (E-utilities esearch) | 2026年10月26日 | (gastroesophageal reflux[mh] OR irritable bowel syndrome[mh]) AND (bread OR wheat OR gluten OR "soft drinks" OR carbonated) AND randomized controlled trial[pt] | 双向 | 107 | |
| Europe PMC | 2026年10月26日 | TITLE:"placebo response" AND TITLE:"irritable bowel" AND (meta-analysis) | 反对性证据 | 7 | |
| Europe PMC | 2026年10月26日 | ("irritable bowel") AND placebo AND ("placebo response") AND "meta-analysis" | 反对性证据 | 487 | |
| Europe PMC | 2026年10月26日 | TITLE:"irritable bowel" AND TITLE:(diet OR dietary) AND TITLE:"network meta-analysis" | 支持性证据 | 7 | |
| Europe PMC | 2026年10月26日 | TITLE:(reflux OR GERD OR heartburn) AND TITLE:(carbohydrate OR sugar OR starch) | 支持性证据 | 17 | |
| Web (curl/WebFetch of guideline page) | 2026年10月26日 | https://www.nice.org.uk/guidance/ng12/chapter/Recommendations-organised-by-site-of-cancer | 指南 | 1 | |
| Web (curl/WebFetch of guideline page) | 2026年10月26日 | https://www.nice.org.uk/guidance/cg184/chapter/1-Recommendations | 指南 | 1 | |
| Web (curl/WebFetch of guideline page) | 2026年10月26日 | https://www.nice.org.uk/guidance/cg61/chapter/Recommendations | 指南 | 1 | |
| Web (curl/WebFetch of guideline page) | 2026年10月26日 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8754510/ (ACG 2022 GERD guideline full text; Europe PMC fullTextXML returned HTTP 500) | 指南 | 1 |
待解决的问题
None beyond C-GUT-01.
核查深度如何？
11 项相关研究：6 项核查了全文（其中 0 项进行了结构化偏倚风险评估），5 项基于摘要核查，0 项仅核查了文献信息。 尚未进行由两名独立审查者完成的正式评估，也尚未进行独立的人类专家审核。
最近一次科学审核: 2026年10月26日
评定结论的变更历史
- 2026年10月25日 · 第 1 阶段 · 初始评估: 基本错误 (低)
- 2026年10月26日 · 第 4 阶段（系统证据审查） · 评定结论已更改: 基本错误 (低) → 基本错误 (中)
Certainty raised: direct randomised data now exist (gluten-free diet responder rates with CIs excluding 85%; blinded wheat challenge null; placebo response benchmark), consistently contradicting the quantitative promise.
新来源: I-GUT-103 I-GUT-104 I-GUT-120 I-GUT-102 I-GUT-109
通俗解释
视频承诺，每 100 个反流或肠易激综合征患者中，有 85 人在停吃面包后十天内就会好转。没有研究表明这一点。在最接近的试验中，约一半的肠易激综合征患者在不吃小麦四周后有所改善，而在一项盲法测试中，小麦引起的症状并不比假对照物更多。许多人在做出任何改变后也会因为心理预期而感觉好一些。饮食可能有帮助，但许多人需要其他治疗，警示信号必须由医生检查。
与该说法相关的研究
支持该说法的研究 (0)
该组中没有研究。
与该说法相矛盾或限制该说法的研究 (10)
-
ACG IBS guideline
Lacy BE et al.. Am J Gastroenterol 2021 · PMID 33315591 · DOI 10.14309/ajg.0000000000001036指南 / 立场声明独立交叉核查已核查摘要A low-FODMAP diet trial is recommended, along with drugs and psychotherapy.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
-
ACG 2022 reflux guideline
Katz PO et al.. Am J Gastroenterol 2022 · PMID 34807007 · DOI 10.14309/ajg.0000000000001538指南 / 立场声明独立交叉核查已核查全文★ 关键研究Weight loss, avoiding late meals and trigger foods help; PPIs are best for erosive oesophagitis.
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
GERD management.
- 研究是如何开展的？
Guideline.
- 实际发现了什么？
Lifestyle + PPI recommendations.
- 研究结果对日常生活意味着什么？
Diet helps; drugs needed for erosive disease.
- 该研究有哪些局限？
Low evidence for some lifestyle advice.
- 它对 Elawady 的具体说法说明了什么？
Mixed for diet claims; contradicts ban.
- 研究结果是否适用于德国和欧洲？
Applicable.
-
Three diets for IBS worked about equally
Rej A et al.. Clin Gastroenterol Hepatol 2022 · PMID 35240330 · DOI 10.1016/j.cgh.2022.02.045随机对照试验独立交叉核查已核查摘要★ 关键研究In 99 IBS patients, about half improved meaningfully after 4 weeks on a gluten-free, low-FODMAP or standard advice diet.
Responder rates 42-58% after 4 weeks; CI excludes 85%
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare three IBS diets.
- 研究是如何开展的？
Randomised trial, 4 weeks.
- 研究了多少人、动物或样本？
99 adults with IBS without constipation.
- 实际发现了什么？
Responders 42%, 55%, 58%; no significant difference.
- 观察到的效应有多大？
Gluten-free 58% (19/33).
- 研究结果对日常生活意味着什么？
Removing wheat can help some people, but not most of them dramatically.
- 该研究有哪些局限？
Small, unblinded, no untreated group.
- 它对 Elawady 的具体说法说明了什么？
Contradicts the 85% figure; supports partial benefit.
- 研究结果是否适用于德国和欧洲？
UK data; applicable to Europe.
- 从该研究中明确不能得出什么结论？
Cannot show a cure or effects beyond 4 weeks.
-
Many IBS patients improve on placebo
Bosman M et al.. Lancet Gastroenterol Hepatol 2021 · PMID 33765447 · DOI 10.1016/S2468-1253(21)00023-6Meta分析独立交叉核查已核查摘要Across 73 trials, about 27% of IBS patients improved overall on dummy pills.
Uncontrolled improvement rates are inflated by placebo response (~27-34%)
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Measure the placebo response in IBS trials.
- 研究是如何开展的？
Meta-analysis of placebo arms.
- 研究了多少人、动物或样本？
73 randomised drug trials.
- 实际发现了什么？
27% global improvement, 34% pain improvement on placebo.
- 观察到的效应有多大？
27.3% (24.3-30.9).
- 研究结果对日常生活意味着什么？
Feeling better after any change does not prove the change caused it.
- 该研究有哪些局限？
Drug trials only; heterogeneous.
- 它对 Elawady 的具体说法说明了什么？
Shows the 85% figure from experience cannot be taken at face value.
- 研究结果是否适用于德国和欧洲？
Applies everywhere.
- 从该研究中明确不能得出什么结论？
Cannot tell how much of a diet effect is placebo.
-
Which diets help irritable bowel syndrome
Cuffe MS et al.. Lancet Gastroenterol Hepatol 2025 · PMID 40258374 · DOI 10.1016/S2468-1253(25)00054-8Meta分析独立交叉核查已核查摘要★ 关键研究A review of 28 trials found that several diets, especially low-FODMAP and a starch- and sugar-reduced diet, improved IBS symptoms more often than usual eating.
Improvement only in a proportion of patients; no cure
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Compare diets for IBS.
- 研究是如何开展的？
Network meta-analysis of randomised trials.
- 研究了多少人、动物或样本？
28 trials, 2338 patients.
- 实际发现了什么？
Low FODMAP and starch/sucrose-reduced diets improved global symptoms; only low FODMAP improved bloating.
- 观察到的效应有多大？
Non-improvement RR 0.41 (starch/sucrose-reduced) and 0.51 (low FODMAP).
- 研究结果对日常生活意味着什么？
Changing diet can help many but not all people with IBS.
- 该研究有哪些局限？
Diet trials hard to blind; few trials for some diets.
- 它对 Elawady 的具体说法说明了什么？
Supports that diet matters; does not support an 85% cure.
- 研究结果是否适用于德国和欧洲？
Applies to European patients.
- 从该研究中明确不能得出什么结论？
Cannot show that bread removal alone cures IBS.
-
Healthy habits linked with less heartburn
Mehta RS et al.. JAMA Intern Med 2021 · PMID 33393976 · DOI 10.1001/jamainternmed.2020.7238队列研究独立交叉核查已核查全文★ 关键研究Women with five healthy habits had half the risk of developing weekly heartburn; normal weight mattered most.
Even all five factors prevent ~37%, not 85%
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Link lifestyle with new reflux symptoms.
- 研究是如何开展的？
10-year prospective cohort.
- 研究了多少人、动物或样本？
42,955 US women.
- 实际发现了什么？
Five healthy habits halved risk; about 37% of cases attributable.
- 观察到的效应有多大？
HR 0.50 (0.42-0.59).
- 研究结果对日常生活意味着什么？
Keeping a normal weight and a healthy diet may prevent many cases of heartburn.
- 该研究有哪些局限？
Self-reported, observational, mostly White women.
- 它对 Elawady 的具体说法说明了什么？
Supports a role of habits but not 'largely caused by eating habits' or bread specifically.
- 研究结果是否适用于德国和欧洲？
Likely applicable to Europe.
- 从该研究中明确不能得出什么结论？
Cannot prove that changing habits removes reflux.
-
UK guideline on heartburn and indigestion
National Institute for Health and Care Excellence (NICE). NICE guideline CG184 2014 (last updated 18 October 2019)指南 / 立场声明独立交叉核查已核查全文★ 关键研究NICE advises lifestyle changes and the lowest effective dose of acid blockers, but long-term full-dose treatment for severe inflammation or a narrowed gullet.
Bleeding requires same-day referral; diet is one element of care
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide care of reflux and indigestion.
- 研究是如何开展的？
National guideline.
- 研究了多少人、动物或样本？
Adults in England.
- 实际发现了什么？
Lifestyle first; step down PPIs; keep PPIs for stricture/severe oesophagitis; eradicate H. pylori in ulcers.
- 观察到的效应有多大？
Not applicable.
- 研究结果对日常生活意味着什么？
Diet matters, but some people need acid blockers long term.
- 该研究有哪些局限？
Older evidence base for some statements.
- 它对 Elawady 的具体说法说明了什么？
Contradicts a blanket ban on acid blockers.
- 研究结果是否适用于德国和欧洲？
Applies directly to Europe.
- 从该研究中明确不能得出什么结论？
Not an evidence synthesis for each claim.
-
Warning signs that need a doctor
National Institute for Health and Care Excellence (NICE). NICE guideline NG12 2015 (last updated 15 April 2026)指南 / 立场声明独立交叉核查已核查全文Difficulty swallowing, vomiting blood, or weight loss with reflux at 55 or older should be checked for cancer.
Dysphagia, weight loss, haematemesis need investigation, not diet trials
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Define when to suspect upper GI cancer.
- 研究是如何开展的？
National guideline.
- 研究了多少人、动物或样本？
Adults in primary care.
- 实际发现了什么？
Dysphagia, weight loss, haematemesis and anaemia trigger referral or endoscopy.
- 观察到的效应有多大？
Not applicable.
- 研究结果对日常生活意味着什么？
Such symptoms must be checked, not treated by diet alone.
- 该研究有哪些局限？
UK thresholds.
- 它对 Elawady 的具体说法说明了什么？
Supports the safety warning.
- 研究结果是否适用于德国和欧洲？
Applies to Europe.
- 从该研究中明确不能得出什么结论？
Not about diet efficacy.
-
UK guideline on irritable bowel syndrome
National Institute for Health and Care Excellence (NICE). NICE guideline CG61 2008 (last updated 04 April 2017)指南 / 立场声明独立交叉核查已核查全文NICE suggests regular meals, plenty of fluids, fewer fizzy drinks and possibly less high-fibre bread, with supervised diets if needed.
Red flags need referral; diet is not a universal cure
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Guide IBS care.
- 研究是如何开展的？
National guideline.
- 研究了多少人、动物或样本？
Adults with IBS.
- 实际发现了什么？
Diet and lifestyle advice first; low FODMAP with expert help; red flags referred.
- 观察到的效应有多大？
Not applicable.
- 研究结果对日常生活意味着什么？
Food changes can help IBS, guided by professionals.
- 该研究有哪些局限？
Older diet evidence.
- 它对 Elawady 的具体说法说明了什么？
Partly supports diet changes; contradicts 'drink only when thirsty' for IBS.
- 研究结果是否适用于德国和欧洲？
Applies to Europe.
- 从该研究中明确不能得出什么结论？
Not proof of cure.
-
In a blind test, wheat was not clearly worse than a fake
Seiler CL et al.. Lancet Gastroenterol Hepatol 2025 · PMID 40706614 · DOI 10.1016/S2468-1253(25)00090-1随机对照试验独立交叉核查已核查摘要★ 关键研究IBS patients who believed wheat or gluten made them ill had similar symptom flares after wheat, gluten or a look-alike sham bar.
Expectation explains much of perceived wheat effects; no evidence of near-universal response
该研究是否支持这一具体说法？ 否 · 方法学质量: 高 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Test whether wheat or gluten really trigger IBS symptoms.
- 研究是如何开展的？
Double-blind sham-controlled crossover trial.
- 研究了多少人、动物或样本？
28 adults with IBS who felt better gluten-free.
- 实际发现了什么？
Symptoms worsened in 39% (wheat), 36% (gluten), 29% (sham); not significantly different.
- 观察到的效应有多大？
RD wheat vs sham 0.11 (-0.16 to 0.35).
- 研究结果对日常生活意味着什么？
Expectations strongly shape symptoms; only some people truly react to wheat.
- 该研究有哪些局限？
Small; short challenges.
- 它对 Elawady 的具体说法说明了什么？
Contradicts the idea that bread is the general cause of IBS.
- 研究结果是否适用于德国和欧洲？
Applicable to Europe.
- 从该研究中明确不能得出什么结论？
Cannot exclude that a minority reacts to wheat.
该组中没有被标记为关键研究的研究。
结果不一或不明确的研究 (1)
-
Cutting sugar reduced acid reflux in a diet trial
Gu C et al.. Am J Gastroenterol 2022 · PMID 35973185 · DOI 10.14309/ajg.0000000000001889随机对照试验独立交叉核查已核查全文★ 关键研究In 98 veterans with reflux, a diet much lower in simple sugars reduced oesophageal acid exposure over 9 weeks compared with a high-sugar diet.
Diet improves reflux measures, but no cure and no 85% response
该研究是否支持这一具体说法？ 部分支持 · 方法学质量: 中 · 证据确定性：见该说法的总体评估
研究通俗解读
- 研究人员想了解什么？
Carbohydrate type and reflux.
- 研究是如何开展的？
Randomised diet trial.
- 研究了多少人、动物或样本？
98 veterans.
- 实际发现了什么？
Less sugar, less acid exposure.
- 观察到的效应有多大？
AET -4.3% vs +3.1%.
- 研究结果对日常生活意味着什么？
Diet can help reflux.
- 该研究有哪些局限？
Mostly men; PPIs continued.
- 它对 Elawady 的具体说法说明了什么？
Partly supports diet effects; not white-flour cure or stopping medicines.
- 研究结果是否适用于德国和欧洲？
Moderate.
- 从该研究中明确不能得出什么结论？
Cannot show that stopping white flour replaces medication.
该组中没有被标记为关键研究的研究。
地区背景
德国 / 欧盟
Not applicable.
埃及
Not applicable.
在我的国家适用什么？
一般科学评估
基本错误 缺乏依据的承诺：试验显示，大约一半的患者在数周后有所改善，而不是十天内 85%，停吃面包也不能彻底治愈。
以下食品安全领域与该说法相关：
- 农药与农药残留
- 真菌毒素（霉菌毒素）
谷物与大米
选择一个国家，查看针对该国已核查的信息。
局限：法律规则描述的是允许什么，而不是每一种食品实际含有什么。检测数据来自样本，只有结合其方法细节才有意义。
参考文献
- ACG Clinical Guideline: Management of Irritable Bowel Syndrome.. Lacy BE et al.. Am J Gastroenterol 2021 · PMID 33315591 · DOI 10.14309/ajg.0000000000001036
- ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.. Katz PO et al.. Am J Gastroenterol 2022 · PMID 34807007 · DOI 10.14309/ajg.0000000000001538
- Efficacy and Acceptability of Dietary Therapies in Non-Constipated Irritable Bowel Syndrome: A Randomized Trial of Traditional Dietary Advice, the Low FODMAP Diet, and the Gluten-Free Diet.. Rej A et al.. Clin Gastroenterol Hepatol 2022 · PMID 35240330 · DOI 10.1016/j.cgh.2022.02.045
- The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.. Bosman M et al.. Lancet Gastroenterol Hepatol 2021 · PMID 33765447 · DOI 10.1016/S2468-1253(21)00023-6
- Efficacy of dietary interventions in irritable bowel syndrome: a systematic review and network meta-analysis.. Cuffe MS et al.. Lancet Gastroenterol Hepatol 2025 · PMID 40258374 · DOI 10.1016/S2468-1253(25)00054-8
- Association of Diet and Lifestyle With the Risk of Gastroesophageal Reflux Disease Symptoms in US Women.. Mehta RS et al.. JAMA Intern Med 2021 · PMID 33393976 · DOI 10.1001/jamainternmed.2020.7238
- Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (NICE guideline CG184). National Institute for Health and Care Excellence (NICE). NICE guideline CG184 2014 (last updated 18 October 2019)
- Suspected cancer: recognition and referral (NICE guideline NG12), section 1.2 upper gastrointestinal tract cancers. National Institute for Health and Care Excellence (NICE). NICE guideline NG12 2015 (last updated 15 April 2026)
- Irritable bowel syndrome in adults: diagnosis and management (NICE guideline CG61). National Institute for Health and Care Excellence (NICE). NICE guideline CG61 2008 (last updated 04 April 2017)
- Effect of gluten and wheat on symptoms and behaviours in adults with irritable bowel syndrome: a single-centre, randomised, double-blind, sham-controlled crossover trial.. Seiler CL et al.. Lancet Gastroenterol Hepatol 2025 · PMID 40706614 · DOI 10.1016/S2468-1253(25)00090-1
- The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure Time and Esophageal Reflux Symptoms: A Randomized Controlled Trial.. Gu C et al.. Am J Gastroenterol 2022 · PMID 35973185 · DOI 10.14309/ajg.0000000000001889